The Canadian pharmaceutical market is one of the most innovative and profitable industries in Canada and considered one of the largest in terms of sales and growth in the world. It is dominated by a handful of multinationals and local generic producers. Although the pharmaceutical industry has not been immune to global economic slowdown pharmaceutical companies continue to enjoy higher margins than any other industry. Nonetheless, it does face challenges from fierce international competition and domestic legislation directed at patent protection measures. To ensure their competitiveness Canadian pharmaceutical companies have relied on TMS experts to provide them with tax recovery opportunities necessary to sustain their growth trends and expectations, especially through continuous waves of legislation change.